Breast Neoplasms: all 12,820 studies
Page 80 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Presentation of First Time Attenders at Lymphedema ClinicsCompletedNCT03687749
- The Malaysian Soy and Mammographic Density StudyStatus unknownNCT03686098Not applicable
- HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast CancerCompletedNCT03685331Phase 1
- Using Hyperpolarized [1-13C]Pyruvate to Detect CardiotoxicityCompletedNCT03685175Early Phase 1
- Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast CancerCompletedNCT03684733
- Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal CureCompletedNCT03684135Not applicable
- Effect of Non-estrogenic Pollen Extract PCC-100 on Hot FlushesCompletedNCT03684096Not applicable
- Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast CancerCompletedNCT03683147Not applicable
- Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.Status unknownNCT03681418Not applicable
- Exercise in Improving Health and Quality of Life in Breast Cancer SurvivorsCompletedNCT03679559Not applicable
- 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
- Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving SurgeryCompletedNCT03677427Not applicable
- Diagnostic Accuracy of Dermal Thickness in LymphedemaCompletedNCT03676127
- Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer SurgeryStatus unknownNCT03676114Phase 4
- Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast CancerTerminatedNCT03674515Not applicable
- Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)TerminatedNCT03674242Phase 2/3
- Peri-gravidic Exposure to Endocrine Disrupting Persistent Organic PollutantsCompletedNCT03673150
- Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast CancerCompletedNCT03669952
- The Tomosynthesis Trial in Bergen - Part 2CompletedNCT03669926Not applicable
- No Axillary Surgery for Early Breast Cancer.CompletedNCT03669705
- Hypo-Fractionated Radiotherapy in Breast CancerCompletedNCT03669497Not applicable
- COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.CompletedNCT03667716Phase 1
- Endogenous Mechanisms of Inactivation of the Endothelium TumorCompletedNCT03667612
- Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyWithdrawnNCT03666819Phase 2
- Abbreviated Breast MRI After Cancer TreatmentCompletedNCT03664778
- Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)CompletedNCT03664687Phase 4
- Diagnosis Value of SEMA4C in Breast CancerStatus unknownNCT03662633
- Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone MetsCompletedNCT03661892Early Phase 1
- BATs in Patients With Breast Cancer and Leptomeningeal MetastasesTerminatedNCT03661424Phase 1
- Magnetic Occult Lesion Localization and Imaging (MOLLI)CompletedNCT03660137Not applicable
- Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)CompletedNCT03658967Phase 2
- Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical MastectomyCompletedNCT03658265Not applicable
- To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.WithdrawnNCT03658213Phase 3
- Physical Activity, Proliferation and Immune Markers in Benign Breast TissueActive, not recruitingNCT03657628Not applicable
- Exercise in Older Women With Breast Cancer During Systemic TherapyCompletedNCT03656731Not applicable
- Acupressure for Pain and Opioid Use Among Breast Cancer PatientsTerminatedNCT03655600Not applicable
- Mindfulness, Breast Cancer and Psycho-Immune DysregulationCompletedNCT03652935Not applicable
- Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.CompletedNCT03651973Not applicable
- Testing of the Cancer Thriving and Surviving Breast Cancer ProgramCompletedNCT03651921Not applicable
- Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer PatientsActive, not recruitingNCT03650894Phase 2
- This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of TreatmentStatus unknownNCT03650738Phase 2
- Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerStatus unknownNCT03647514Not applicable
- The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT03647280Not applicable
- Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast CancerWithdrawnNCT03644589Phase 2
- Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.Status unknownNCT03644329Not applicable
- RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)Active, not recruitingNCT03643861Not applicable
- Evaluating a Novel Web-based Intervention for Breast Cancer SurvivorsCompletedNCT03643640Not applicable
- Olaparib + Sapacitabine in BRCA Mutant Breast CancerActive, not recruitingNCT03641755Phase 1
- Carbon Dye Tattooing of Biopsied Axillary Node in Breast CancerCompletedNCT03640819Not applicable
- Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant TherapyStatus unknownNCT03638648Phase 2
- ePainQ - Feasibility StudyStatus unknownNCT03638414Not applicable
- Prognostic Significance of Bioscore in Nonmetastatic Breast CancerCompletedNCT03638219
- Eribulin in Brain Metastases From HER2-negative Breast CancerWithdrawnNCT03637868Phase 2
- Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast CancerStatus unknownNCT03637738Not applicable
- Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast CancerTerminatedNCT03636776Not applicable
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Active, not recruitingNCT03635632Phase 1
- Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast CancerWithdrawnNCT03634150Phase 1/2
- Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening DecisionsCompletedNCT03631758Not applicable
- Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast CarcinomaStatus unknownNCT03630913Not applicable
- Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1TerminatedNCT03630809Phase 2
- Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer RelapseTerminatedNCT03630653Not applicable
- Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy VolunteersTerminatedNCT03630601Not applicable
- RANKL Inhibition and Breast Tissue BiomarkersCompletedNCT03629717Early Phase 1
- Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast CancerCompletedNCT03628066Phase 2
- Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic TreatmentStatus unknownNCT03625635Not applicable
- CFI-400945 in Patients With Advanced/Metastatic Breast CancerActive, not recruitingNCT03624543Phase 2
- CBPR - BRCA Genetic Testing Among Orthodox JewsCompletedNCT03624088Not applicable
- Autoantibodies in Breast Cancer DetectionTerminatedNCT03623945
- M7824 in Treating Patients With Stage II-III HER2 Positive Breast CancerCompletedNCT03620201Phase 1
- Sentinel Lymph Node Mapping With Near Infrared Fluorescent MarkersCompletedNCT03619967Not applicable
- Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric CancerCompletedNCT03619681Phase 1
- Assessment of Sensory Gating, Attention, and Executive Control in Breast CancerActive, not recruitingNCT03619083
- The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.TerminatedNCT03619044Not applicable
- KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer SurgeryCompletedNCT03618433Not applicable
- Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerStatus unknownNCT03617341
- Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBCActive, not recruitingNCT03616886Phase 1/2
- Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast IrradiationStatus unknownNCT03616626Not applicable
- Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active, not recruitingNCT03616587Phase 1
- Plant-based Diets and Risk of Cancer in the Adventist Health Study-2Active, not recruitingNCT03615599
- Survey Study: Financial Impact of Breast Cancer TreatmentCompletedNCT03615573
- Serratus Plane Block in Preventing Postoperative Pain of MastectomyCompletedNCT03615430Not applicable
- ANG1005 in Leptomeningeal Disease From Breast CancerStatus unknownNCT03613181Phase 3
- The Impact of SPC on Advanced Breast Cancer PatientsCompletedNCT03612934
- Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast CarcinomaCompletedNCT03612648Not applicable
- Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer PatientsWithdrawnNCT03611985Phase 1/2
- Emotions Immunology and Breast CancerCompletedNCT03609671Not applicable
- Adjuvant Palbociclib in Elderly Patients With Breast CancerActive, not recruitingNCT03609047Phase 2
- Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502TerminatedNCT03609021
- Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome SequencingCompletedNCT03608865Phase 2
- Non-contrast DWI for Supplemental ScreeningActive, not recruitingNCT03607552
- Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese PatientsCompletedNCT03606616
- Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.Status unknownNCT03606369Phase 2/3
- Follow-up of Elderly Patients in Ambulatory SurgeryStatus unknownNCT03604666
- BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast CancerCompletedNCT03603197Phase 2
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast CancerCompletedNCT03600090Phase 1
- Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast CancerCompletedNCT03599453Early Phase 1
- Local Compression Seroma DIminution Objective (CLODIS)TerminatedNCT03598712Phase 3
- Role of Sorcin and Annexin A3 in Breast Cancer PatientsStatus unknownNCT03598660
- SHR9549 in ER Positive HER2 Negative Advanced Breast CancerTerminatedNCT03596658Phase 1